$418 Million is the total value of Adamant Biomedical Investments AG's 101 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 21.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Sell | CELGENE CORPORATION | $20,825,000 | +6.3% | 186,170 | -9.9% | 4.98% | +1.8% |
| BIIB | Sell | BIOGEN IDEC INC | $18,076,000 | -0.7% | 53,250 | -3.2% | 4.32% | -4.9% |
| GILD | Sell | GILEAD SCIENCES INC | $17,004,000 | -18.7% | 180,390 | -8.1% | 4.06% | -22.1% |
| AMGN | Sell | AMGEN INC | $15,133,000 | +7.7% | 95,000 | -5.0% | 3.62% | +3.2% |
| B108PS | Sell | ACTAVIS PLC | $13,280,000 | +5.6% | 51,590 | -1.0% | 3.17% | +1.1% |
| UNH | Sell | UNITEDHEALTH GROUP INCORPORATED | $11,625,000 | +5.3% | 115,000 | -10.2% | 2.78% | +0.9% |
| MYL | Sell | MYLAN INC | $11,274,000 | +7.8% | 200,000 | -13.0% | 2.70% | +3.2% |
| CTRX | Buy | CATAMARAN CORPORATION | $10,735,000 | +104.6% | 206,820 | +51.3% | 2.57% | +95.9% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $10,547,000 | +6.0% | 57,000 | -5.0% | 2.52% | +1.5% |
| MDT | Sell | MEDTRONIC INC | $8,772,000 | -5.6% | 121,500 | -19.0% | 2.10% | -9.6% |
| VRTX | VERTEX PHARMACEUTICALS INC | $8,672,000 | +5.8% | 73,000 | 0.0% | 2.07% | +1.3% | |
| REGN | Buy | REGENERON PHARMACEUTICALS INC | $8,615,000 | +32.8% | 21,000 | +16.7% | 2.06% | +27.1% |
| MCK | MCKESSON CORPORATION | $8,511,000 | +6.6% | 41,000 | 0.0% | 2.03% | +2.1% | |
| EARS | AURIS MEDICAL HOLDING AG | $8,462,000 | -15.4% | 2,169,625 | 0.0% | 2.02% | -19.0% | |
| MNKKQ | MALLINCKRODT PUBLIC LIMITED COMPANY | $7,922,000 | +9.8% | 80,000 | 0.0% | 1.89% | +5.2% | |
| ABT | Sell | ABBOTT LABORATORIES | $7,788,000 | -6.4% | 173,000 | -13.5% | 1.86% | -10.3% |
| AGN | ALLERGAN INC | $7,441,000 | +19.3% | 35,000 | 0.0% | 1.78% | +14.3% | |
| ILMN | Sell | ILLUMINA INC | $7,383,000 | +4.7% | 40,000 | -7.0% | 1.76% | +0.3% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $6,509,000 | +650.7% | 205,000 | +485.7% | 1.56% | +620.4% |
| MDVN | Buy | MEDIVATION INC | $6,475,000 | +227.5% | 65,000 | +225.0% | 1.55% | +214.0% |
| CAH | Sell | CARDINAL HEALTH INC | $6,458,000 | -17.9% | 80,000 | -23.8% | 1.54% | -21.4% |
| ISIS | Sell | ISIS PHARMACEUTICALS INC | $6,174,000 | +13.6% | 100,000 | -28.6% | 1.48% | +8.8% |
| AKRXQ | Buy | AKORN INC | $5,792,000 | +166.2% | 160,000 | +166.7% | 1.38% | +154.9% |
| LLY | ELI LILLY AND COMPANY | $5,519,000 | +6.4% | 80,000 | 0.0% | 1.32% | +1.9% | |
| HSP | New | HOSPIRA INC | $5,512,000 | – | 90,000 | +100.0% | 1.32% | – |
| CNC | Sell | CENTENE CORPORATION | $5,360,000 | -17.4% | 51,610 | -34.2% | 1.28% | -20.9% |
| SLXP | Sell | SALIX PHARMACEUTICALS INC | $5,172,000 | -57.7% | 45,000 | -42.5% | 1.24% | -59.5% |
| CI | CIGNA CORPORATION | $5,146,000 | +13.5% | 50,000 | 0.0% | 1.23% | +8.7% | |
| INCY | INCYTE CORPORATION | $5,118,000 | +49.0% | 70,000 | 0.0% | 1.22% | +42.7% | |
| MOH | Sell | MOLINA HEALTHCARE INC | $4,909,000 | -11.4% | 91,710 | -30.0% | 1.17% | -15.2% |
| ESRX | EXPRESS SCRIPTS HOLDING COMPANY | $4,826,000 | +19.9% | 57,000 | 0.0% | 1.15% | +14.8% | |
| BAX | BAXTER INTERNATIONAL INC | $4,764,000 | +2.1% | 65,000 | 0.0% | 1.14% | -2.1% | |
| BKD | Sell | BROOKDALE SENIOR LIVING INC | $4,750,000 | +7.1% | 129,540 | -5.9% | 1.14% | +2.5% |
| WX | New | WUXI PHARMATECH INC | $4,714,000 | – | 140,000 | +100.0% | 1.13% | – |
| LGND | New | LIGAND PAHRAMCEUTICALS INCORPORATED | $4,325,000 | – | 81,280 | +100.0% | 1.03% | – |
| HUM | Sell | HUMANA INC | $4,309,000 | -5.5% | 30,000 | -14.3% | 1.03% | -9.5% |
| JNJ | Sell | JOHNSON & JOHNSON | $4,183,000 | -12.8% | 40,000 | -11.1% | 1.00% | -16.5% |
| LCI | Buy | LANNET CO INC | $4,040,000 | +10.6% | 94,210 | +17.8% | 0.97% | +5.9% |
| HCA | Buy | HCA HOLDINGS INC | $4,036,000 | +27.2% | 55,000 | +22.2% | 0.96% | +21.8% |
| ABBV | New | ABBVIE INC | $3,926,000 | – | 60,000 | +100.0% | 0.94% | – |
| SYK | Sell | STRYKER CORPORATION | $3,915,000 | -15.7% | 41,500 | -27.8% | 0.94% | -19.2% |
| AET | Sell | AETNA INC | $3,909,000 | -19.6% | 44,000 | -26.7% | 0.93% | -23.0% |
| ANTM | New | ANTHEM INC | $3,770,000 | – | 30,000 | +100.0% | 0.90% | – |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $3,542,000 | +38.4% | 60,000 | +20.0% | 0.85% | +32.6% |
| PRGO | Sell | PERRIGO COMPANY PLC | $3,333,000 | -19.7% | 20,000 | -35.0% | 0.80% | -23.1% |
| STJ | Sell | ST JUDE MEDICAL INC | $3,317,000 | -15.1% | 51,000 | -21.5% | 0.79% | -18.7% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $3,275,000 | +2.0% | 20,000 | 0.0% | 0.78% | -2.2% | |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $3,254,000 | -9.8% | 36,000 | -28.0% | 0.78% | -13.7% |
| CVS | Sell | CVS HEALTH CORPORATION | $2,889,000 | -19.3% | 30,000 | -33.3% | 0.69% | -22.7% |
| ENDP | ENDO INTERNATIONAL PLC | $2,885,000 | +5.5% | 40,000 | 0.0% | 0.69% | +1.2% | |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDadr | $2,876,000 | -55.4% | 50,000 | -58.3% | 0.69% | -57.3% |
| ZBH | ZIMMER HOLDINGS INC | $2,836,000 | +12.8% | 25,000 | 0.0% | 0.68% | +8.1% | |
| CLVS | New | CLOVIS ONCOLOGY INC | $2,800,000 | – | 50,000 | +100.0% | 0.67% | – |
| ALKS | ALKERMES PLC | $2,635,000 | +36.6% | 45,000 | 0.0% | 0.63% | +31.0% | |
| CERN | CERNER CORPORATION | $2,586,000 | +8.5% | 40,000 | 0.0% | 0.62% | +3.9% | |
| RDY | Sell | DR REDDY'S LABORATORIES LIMITEDadr | $2,522,000 | -40.0% | 50,000 | -37.5% | 0.60% | -42.5% |
| CBST | CUBIST PHARMACEUTICALS INC | $2,416,000 | +51.8% | 24,000 | 0.0% | 0.58% | +45.3% | |
| QGEN | Sell | QIAGEN NV | $2,343,000 | -54.8% | 100,000 | -60.1% | 0.56% | -56.8% |
| SHPG | SHIRE PLCsponsored adr | $2,338,000 | -18.0% | 11,000 | 0.0% | 0.56% | -21.4% | |
| MRK | MERCK & CO INC | $2,272,000 | -4.2% | 40,000 | 0.0% | 0.54% | -8.3% | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $2,231,000 | +24.2% | 23,000 | 0.0% | 0.53% | +19.0% | |
| PRXL | New | PAREXEL INTERNATIONAL CORPORATION | $2,222,000 | – | 40,000 | +100.0% | 0.53% | – |
| ISRG | INTUITIVE SURGICAL INC | $2,116,000 | +14.6% | 4,000 | 0.0% | 0.51% | +9.8% | |
| ARIA | ARIAD PHARMACEUTICALS INC | $2,061,000 | +27.2% | 300,000 | 0.0% | 0.49% | +22.0% | |
| DVA | DAVITA HEALTHCARE PARTNERS I | $1,969,000 | +3.5% | 26,000 | 0.0% | 0.47% | -0.8% | |
| BIB | Sell | PROSHARES TRUST | $1,882,000 | -63.8% | 15,000 | -70.0% | 0.45% | -65.3% |
| PFE | PFIZER INC | $1,869,000 | +5.4% | 60,000 | 0.0% | 0.45% | +0.9% | |
| EW | EDWARDS LIFESCIENCES CORPORATION | $1,847,000 | +24.7% | 14,500 | 0.0% | 0.44% | +19.2% | |
| THC | New | TENET HEALTHCARE CORPORATION | $1,773,000 | – | 35,000 | +100.0% | 0.42% | – |
| VAR | VARIAN MEDICAL SYSTEMS INC | $1,730,000 | +8.0% | 20,000 | 0.0% | 0.41% | +3.5% | |
| OCR | Buy | OMNICARE INC | $1,677,000 | +49.6% | 23,000 | +27.8% | 0.40% | +43.2% |
| BCR | BARD C R INC | $1,666,000 | +16.7% | 10,000 | 0.0% | 0.40% | +11.8% | |
| HNT | New | HEALTH NET INC | $1,606,000 | – | 30,000 | +100.0% | 0.38% | – |
| MNKD | MANNKIND CORPORATION | $1,564,000 | -11.8% | 300,000 | 0.0% | 0.37% | -15.6% | |
| ATHN | ATHENAHEALTH INC | $1,457,000 | +10.6% | 10,000 | 0.0% | 0.35% | +5.8% | |
| MDCO | MEDICINES COMPANY | $1,384,000 | +24.0% | 50,000 | 0.0% | 0.33% | +18.6% | |
| SGEN | SEATTLE GENETICS INC | $1,285,000 | -13.6% | 40,000 | 0.0% | 0.31% | -17.3% | |
| ACHN | Buy | ACHILLION PHARMACEUTICALS INC | $1,225,000 | +53.5% | 100,000 | +25.0% | 0.29% | +47.2% |
| P103PS | NPS PHARMACEUTICALS INC | $1,216,000 | +37.6% | 34,000 | 0.0% | 0.29% | +31.7% | |
| RMD | Sell | RESMED INC | $1,121,000 | -61.7% | 20,000 | -66.4% | 0.27% | -63.3% |
| F113PS | Sell | COVIDIEN PLC | $1,023,000 | -80.3% | 10,000 | -83.3% | 0.24% | -81.1% |
| NBIX | NEUROCRINE BIOSCIENCES INC | $1,005,000 | +42.6% | 45,000 | 0.0% | 0.24% | +36.4% | |
| UTHR | Sell | UNITED THERAPEUTICS CORPORATION | $906,000 | -53.1% | 7,000 | -53.3% | 0.22% | -55.0% |
| ABC | AMERISOURCEBERGEN CORPORATION | $902,000 | +16.7% | 10,000 | 0.0% | 0.22% | +11.9% | |
| MYGN | MYRIAD GENETICS INC | $817,000 | -11.8% | 24,000 | 0.0% | 0.20% | -15.6% | |
| IMMU | IMMUNOMEDICS INC | $720,000 | +29.0% | 150,000 | 0.0% | 0.17% | +23.7% | |
| WCG | WELLCARE HEALTH PLANS INC | $656,000 | +35.8% | 8,000 | 0.0% | 0.16% | +29.8% | |
| IPXL | IMPAX LABORATORIES INC | $634,000 | +33.8% | 20,000 | 0.0% | 0.15% | +28.8% | |
| Q | New | QUINTILES TRANSNATIONAL HOLDINGS INC | $589,000 | – | 10,000 | +100.0% | 0.14% | – |
| HALO | HALOZYME THERAPEUTICS INC | $579,000 | +6.0% | 60,000 | 0.0% | 0.14% | +1.5% | |
| CLDX | CELLDEX THERAPEUTICS INC | $548,000 | +40.9% | 30,000 | 0.0% | 0.13% | +35.1% | |
| THRX | Sell | THERAVANCE INC | $495,000 | -71.0% | 35,000 | -65.0% | 0.12% | -72.4% |
| AFFX | Sell | AFFYMETRIX INC | $494,000 | -38.1% | 50,000 | -50.0% | 0.12% | -40.7% |
| EXEL | EXELIXIS INC | $432,000 | -5.9% | 300,000 | 0.0% | 0.10% | -10.4% | |
| INFI | INFINITY PHARMACEUTICALS INC | $287,000 | +25.9% | 17,000 | 0.0% | 0.07% | +21.1% | |
| IMS | New | IMS HEALTH HOLDINGS INC | $256,000 | – | 10,000 | +100.0% | 0.06% | – |
| TBPH | THERAVANCE BIOPHARMA INC | $171,000 | -35.0% | 11,428 | 0.0% | 0.04% | -37.9% | |
| GERN | GERON CORPORATION | $146,000 | +62.2% | 45,000 | 0.0% | 0.04% | +59.1% | |
| CBSTZ | CUBIST PHARMACEUTICALS INCright 99/99/9999 | $3,000 | -66.7% | 80,000 | 0.0% | 0.00% | -50.0% | |
| AST | New | ASTERIAS BIOTHERAPEUTICS INC | $6,000 | – | 1,875 | +100.0% | 0.00% | – |
| BTXWS | New | BIOTIME INCw exp 10/01/2018 | $2,000 | – | 2,294 | +100.0% | 0.00% | – |
| DNDNQ | Exit | DENDREON CORP | $0 | – | -50,000 | -100.0% | -0.02% | – |
| ONVO | Exit | ORGANOVO HLDGS INC | $0 | – | -50,000 | -100.0% | -0.08% | – |
| LDRH | Exit | LDR HLDG CORP | $0 | – | -33,000 | -100.0% | -0.26% | – |
| T107PS | Exit | WRIGHT MED GROUP INC | $0 | – | -38,000 | -100.0% | -0.29% | – |
| TNA | Exit | DIREXION SHS ETF TRdly smcap bull3x | $0 | – | -30,000 | -100.0% | -0.48% | – |
| RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -130,000 | -100.0% | -0.63% | – |
| PODD | Exit | INSULET CORP | $0 | – | -80,000 | -100.0% | -0.74% | – |
| V107SC | Exit | WELLPOINT INC | $0 | – | -38,000 | -100.0% | -1.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CELGENE CORPORATION | 2 | Q4 2014 | 5.0% |
| GILEAD SCIENCES INC | 2 | Q4 2014 | 5.2% |
| BIOGEN IDEC INC | 2 | Q4 2014 | 4.5% |
| AMGEN INC | 2 | Q4 2014 | 3.6% |
| ACTAVIS PLC | 2 | Q4 2014 | 3.2% |
| UNITEDHEALTH GROUP INCORPORATED | 2 | Q4 2014 | 2.8% |
| MYLAN INC | 2 | Q4 2014 | 2.7% |
| ALEXION PHARMACEUTICALS INC | 2 | Q4 2014 | 2.5% |
| AURIS MEDICAL HOLDING AG | 2 | Q4 2014 | 2.5% |
| MEDTRONIC INC | 2 | Q4 2014 | 2.3% |
View Adamant Biomedical Investments AG's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Auris Medical Holding AG | February 13, 2015 | 2,169,625 | 7.5% |
View Adamant Biomedical Investments AG's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2015-02-13 |
| SC 13G | 2015-02-13 |
| 13F-HR | 2014-11-14 |
| 13F-NT | 2014-08-07 |
| 13F-NT | 2014-04-29 |
| 13F-NT | 2014-02-03 |
| 13F-NT | 2013-10-31 |
| 13F-NT | 2013-07-24 |
| 13F-NT | 2013-05-13 |
| 13F-NT | 2013-02-14 |
View Adamant Biomedical Investments AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.